Type III Interferon Attenuates a Vesicular Stomatitis Virus-Based Vaccine Vector
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Type III Interferon Attenuates a Vesicular Stomatitis Virus-Based Vaccine Vector
Authors
Keywords
-
Journal
JOURNAL OF VIROLOGY
Volume 88, Issue 18, Pages 10909-10917
Publisher
American Society for Microbiology
Online
2014-07-10
DOI
10.1128/jvi.01910-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Distance Interferon Signaling within the Brain Blocks Virus Spread
- (2014) A. N. van den Pol et al. JOURNAL OF VIROLOGY
- Highly Attenuated Recombinant Vesicular Stomatitis Virus VSV-12'GFP Displays Immunogenic and Oncolytic Activity
- (2012) A. N. van den Pol et al. JOURNAL OF VIROLOGY
- Vesicular stomatitis virus as a treatment for colorectal cancer
- (2011) J H Stewart et al. CANCER GENE THERAPY
- T-cell-inducing vaccines - what’s the future
- (2011) Sarah C. Gilbert IMMUNOLOGY
- Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells
- (2011) Tamaki Okabayashi et al. VIRUS RESEARCH
- Antitumor activity of Type I and Type III interferons in BNL hepatoma model
- (2010) Walid Abushahba et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Unique Th1/Th2 Phenotypes Induced during Priming and Memory Phases by Use of Interleukin-12 (IL-12) or IL-28B Vaccine Adjuvants in Rhesus Macaques
- (2010) M. P. Morrow et al. Clinical and Vaccine Immunology
- Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection
- (2010) Andrew J. Muir et al. HEPATOLOGY
- Lambda Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal Tracts Resistant to Viral Infections
- (2010) M. Mordstein et al. JOURNAL OF VIROLOGY
- Lambda Interferon Is the Predominant Interferon Induced by Influenza A Virus Infection In Vivo
- (2010) N. A. Jewell et al. JOURNAL OF VIROLOGY
- IL-28B/IFN-λ3 Drives Granzyme B Loading and Significantly Increases CTL Killing Activity in Macaques
- (2010) Matthew P Morrow et al. MOLECULAR THERAPY
- Interferon-λ in HCV Infection and Therapy
- (2010) Nicole E. Pagliaccetti et al. Viruses-Basel
- Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity
- (2009) M. P. Morrow et al. BLOOD
- Despite IFN-λ receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines
- (2009) K Witte et al. GENES AND IMMUNITY
- Interferon-λ Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family
- (2009) Hans Henrik Gad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Type III Interferon Activity by Orthopoxvirus Immunomodulatory Proteins
- (2009) Prasanthi Bandi et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Some Attenuated Variants of Vesicular Stomatitis Virus Show Enhanced Oncolytic Activity against Human Glioblastoma Cells relative to Normal Brain Cells
- (2009) G. Wollmann et al. JOURNAL OF VIROLOGY
- rVSV(MΔ51)-M3 Is an Effective and Safe Oncolytic Virus for Cancer Therapy
- (2008) Lan Wu et al. HUMAN GENE THERAPY
- Interferon-λ Contributes to Innate Immunity of Mice against Influenza A Virus but Not against Hepatotropic Viruses
- (2008) Markus Mordstein et al. PLoS Pathogens
- IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In Vivo
- (2008) Caroline Sommereyns et al. PLoS Pathogens
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now